Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES1 | P23141 | 2/20 | 0.37 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | BRPF1 | P55201 | 1/20 | 0.33 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.33 |
| ▸ | PPOX | P50336 | 1/20 | 0.32 |
| ▸ | TRPM2 | O94759 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7393535 | 0.77 | ALDH1A1 (0.41) | CES1DNMT1TSHRAKR1B1POLB | |
| SCHEMBL7393532 | 0.77 | ALDH1A1 (0.41) | CES1DNMT1TSHRAKR1B1POLB | |
| SCHEMBL7398964 | 0.75 | CREBBP (0.42) | TSHRPOLBBRPF1CREBBPCYP3A4 | |
| SCHEMBL6200808 | 0.75 | CREBBP (0.42) | TSHRPOLBBRPF1CREBBPCYP3A4 | |
| SCHEMBL7485845 | 0.72 | TGM2 (0.53) | CES1TSHRBRPF1CREBBPPPOX | |
| SCHEMBL14992148 | 0.64 | PPOX (0.46) | CES1TSHRPPOX | |
| SCHEMBL31437645 | 0.64 | POLB (0.37) | TSHRPOLBBRPF1CREBBP | |
| SCHEMBL12749055 | 0.62 | CREBBP (0.54) | CES1TSHRPOLBBRPF1CREBBP | |
| SCHEMBL12749106 | 0.62 | CREBBP (0.54) | CES1TSHRPOLBBRPF1CREBBP | |
| SCHEMBL7908117 | 0.60 | ROS1 (0.54) | TSHRBRPF1CREBBP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6201119-B1 | 2,3,4,5-TETRAHYDRO-1H-1,4-BENZODIAZEPIN-9-AMINE COMPOUNDS USEFUL AS INTERMEDIATES TO ANTIVIRALS | JANSSEN PHARMACEUTICA N.V. (BE) | 2001-03-13 | — | — | US | disclosed |
| US-5371079-A | Administering to inhibit replication of HIV-1 in human cells | JANSSEN PHARMACEUTICA N.V. (BE) | 1994-12-06 | — | — | US | disclosed |
| US-5270464-A | Anti-HIV-1 tetrahydroimidazo[1,4]benzodiazepin-2-(thi) ones | JANSSEN PHARMACEUTICA N.V. (BE) | 1993-12-14 | — | — | US | disclosed |
| EP-0384522-B1 | Antiviral tetrahydroimidazo[1,4]benzodiazepin-2-thiones | JANSSEN PHARMACEUTICA N.V. (BE) | 1993-01-13 | — | — | EP | disclosed |
| EP-0384522-A1 | Antiviral tetrahydroimidazo[1,4]benzodiazepin-2-thiones | JANSSEN PHARMACEUTICA N.V. (BE) | 1990-08-29 | — | — | EP | disclosed |